drugset / Trial / NCT05312970

Varithena Versus Endothermal Ablation of the Great Saphenous Vein (VERITAS)

NCT05312970

Phase 4 Terminated 43 enrolled Boston Scientific Corporation
RandomizedParallel-groupOpen-labelOther

Summary

The purpose of this study is to observe insights into the benefits of Varithena compared to Endothermal Ablation (ETA) in the treatment of the great saphenous vein.

Timeline

Start
2023-02-10
Primary completion
2024-04-04
Completion
2024-04-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Polidocanol Other / unclassified 1 %

Indications